Skip to main content
Contact us

Chemical CDMO companies
Custom Synthesis and Chemical CMO Solutions

Your Trusted Partners for Custom Synthesis and Chemical CDMO Services

Showing 72 facilities
SENN Chemicals | R&D and Kilo Lab | Dielsdorf, Switzerland
Switzerland

SENN Chemicals | R&D and Kilo Lab | Dielsdorf, Switzerland

Senn Chemicals

Swiss peptide and peptide intermediates R&D site with SPPS, LPPS, hybrid synthesis, kilo lab scale up, purification and analytics.

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

CATEGORY / PRODUCT: COSMETICS, CHEMICAL-SYNTHETIC, SERVICES, PARTICLE ENGINEERING

BATCH SIZE: Small

SENN Chemicals | Small Scale GMP Lab | Dielsdorf, Switzerland
Switzerland

SENN Chemicals | Small Scale GMP Lab | Dielsdorf, Switzerland

Senn Chemicals

Small scale GMP peptide and organic synthesis lab for clinical, niche and high value projects requiring flexible cGMP production.

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC, PARTICLE ENGINEERING

BATCH SIZE: Small

SENN Chemicals | GMP Production | Dielsdorf, Switzerland
Switzerland

SENN Chemicals | GMP Production | Dielsdorf, Switzerland

Senn Chemicals

Swiss cGMP production site for LPPS, SPPS and hybrid peptide manufacturing from pilot to early commercial scale.

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

BATCH SIZE: Large, Medium

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC, PARTICLE ENGINEERING

SENN India | Non-GMP Plant | Hyderabad, India
India

SENN India | Non-GMP Plant | Hyderabad, India

Senn Chemicals

Large scale non GMP manufacturing site for peptide intermediates, organic synthesis, LPPS operations and scale up production.

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: APAC

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: COSMETICS, CHEMICAL-SYNTHETIC, SERVICES, PARTICLE ENGINEERING

SENN India | R&D Lab | Hyderabad, India
India

SENN India | R&D Lab | Hyderabad, India

Senn Chemicals

R&D centre for peptide and organic chemistry with SPPS, purification, lyophilisation, analytics and particle engineering support.

SERVICES: Logistics, Development services, Analytical / QC services, Quality Assurance services, Packaging

REGION: APAC

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC, PARTICLE ENGINEERING

BATCH SIZE: Small

Viswa Laboratories Pvt Ltd
India

Viswa Laboratories Pvt Ltd

Viswa Laboratories Private Limited

CRAMS/CDMO, APIs, Intermediates and specialty chemicals.

MARKETS: EMA (EU), NMPA (China), ANVISA (Brazil), Russian Health Authorities, CDSCO (India)

REGION: APAC

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

BSL (Biological Safety Level): 1, 2

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (R) Respiratory system

CONTROLLED SUBSTANCES: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

COMPLIANCE: World Health Organization (GMP / HACCP)

Pharmaron API Commercial Synthesis Shaoxing (China)
China

Pharmaron API Commercial Synthesis Shaoxing (China)

Pharmaron

Commercial API Small Molecules /Peptides Synthesis.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (V09-10) Radiopharmaceuticals, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MARKETS: NMPA (China), FDA (USA)

REGION: APAC

COMPLIANCE: FDA (cGMP), ISO, NMPA (China GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

Pharmaron API Commercial Synthesis Cramlington (UK)
United Kingdom

Pharmaron API Commercial Synthesis Cramlington (UK)

Pharmaron

Commercial API Small Molecules Synthesis.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)

REGION: Europe

COMPLIANCE: FDA (cGMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

Pharmaron API Commercial Synthesis Coventry (US)
United States

Pharmaron API Commercial Synthesis Coventry (US)

Pharmaron

Commercial API Small Molecules Synthesis.

THERAPEUTIC AREAS OF EXPERTISE (ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK), MFDS (South Korea), TGA (Australia)

COMPLIANCE: FDA (cGMP), ISO, ECOVADIS

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

REGION: North America

Indena Settala
Italy

Indena Settala

Indena

GMP-compliant and FDA-inspected facility that specializes in complex APIs and high-potent compounds up to OEB 6.

MARKETS: TGA (Australia), Rest of World, EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India)

BATCH SIZE: Small, Medium, Large

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day), 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day)

COMPLIANCE: NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP), FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP)

SERVICES: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

REGION: Europe

USE: Human, Veterinary

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

Hikal Ltd | Bangalore, India
India

Hikal Ltd | Bangalore, India

Hikal Ltd.

cGMP Process Development, Scale-up and Manufacturing of Small Molecule APIs, NMEs and Intermediates from grams to tones.

OEB (Occupational Exposure Banding): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World

REGION: APAC

COMPLIANCE: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), COFEPRIS, Halal Research Council, ECOVADIS, TGA (Australia GMP), EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

CATEGORY / PRODUCT: COSMETICS, NUTRACEUTICALS, CHEMICAL-SYNTHETIC, SERVICES

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services

THERAPEUTIC AREAS OF EXPERTISE (ATC): (C) Cardiovascular system, (D) Dermatologicals, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (V06) Nutrients

CARBOGEN AMCIS | Vionnaz
Switzerland

CARBOGEN AMCIS | Vionnaz

CARBOGEN AMCIS

Highly Potent APIs development and small-scale cGMP production including chromatography and lyophilization.

MARKETS: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), CDSCO (India), TGA (Australia)

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), EMA (EU GMP), World Health Organization (GMP / HACCP)

USE: Human, Veterinary

CATEGORY / PRODUCT: CHEMICAL-SYNTHETIC

SERVICES: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services

OEB (Occupational Exposure Banding): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

BATCH SIZE: Small

More facilities on the network

Register to unlock the full catalog with contact details and locations.

+48 more facilities

Create free account

The pharmaceutical supply chain relies heavily on chemical CDMO partners who can translate laboratory chemistry into cGMP-compliant production. Whether you need rapid custom synthesis of a reference compound or multi-ton Active Pharmaceutical Ingredient (API) supply, the right chemical specialist can compress timelines, ensure regulatory readiness, and free your team to focus on discovery while leveraging advanced synthetic methodologies.

How to Choose a Chemical CMO

Selecting a reliable partner starts with four pillars:

  1. Regulatory performance: Recent FDA/EMA audits, robust quality metrics, and a transparent deviation-tracking system for ICH-compliant chemistry.
  2. Technical breadth: Proven routes for heterocyclic chemistry, high-pressure hydrogenations, cryogenic reactions, and photoredox-enabled continuous-flow processes.
  3. Scale-up flexibility: Reactors from 50 L glass to 8 m³ stainless steel allow seamless transition from tox batches to commercial volumes with QbD-driven process chemistry.
  4. Cultural alignment: Bilingual project managers, digital batch records, and real-time KPIs keep cross-functional teams informed throughout synthetic route optimization.

Ask for tech-transfer success rates, average batch-to-batch variability, and on-time-in-full (OTIF) scores to benchmark contenders.

Key Services Offered by Chemical Contract Manufacturers

Top chemical CDMO providers deliver an end-to-end suite that accelerates molecule development:

  • Process development & optimization: DoE-guided studies, impurity mapping, and solvent sustainability strategies reduce cost per kilo.
  • Small-molecule & custom synthesis: Multistep routes for complex scaffolds, chiral center control, and scalable photocatalysis.
  • Analytical & quality control: UHPLC, GC-MS, and NMR profiling ensure every lot meets EP / USP standards.
  • RSM, intermediate, and API manufacturing: Kilo labs and pilot plants operate under ISO 9001, ISO 14001, and full cGMP.
  • Formulation precursors: Salt-selection libraries, polymorph screens, and pre-formulation support bridge chemistry to dosage.

Advantages of Partnering with a Chemical CDMO

  • Capital efficiency: Outsourcing avoids multimillion-euro reactor investments and ongoing validation costs.
  • Speed & scalability: Seasoned scale-up engineers cut months out of tech transfer and can ramp production in parallel sites.
  • Regulatory expertise: Dossier authoring, DMF preparation, and remote inspection readiness streamline approvals.
  • Innovation access: Flow chemistry, biocatalysis, and AI-guided route scouting reduce waste and improve yields.
  • Risk mitigation: Dual sourcing, backward-integrated raw materials, and geo-diversified warehousing secure supply continuity.

Relevant Chemical CDMOs

  • Cambrex: Specialized in early development of small molecule pharmaceutical products. [See CDMO profile]
  • CARBOGEN AMCIS: Development and manufacturing of intermediates, fine chemicals and APIs. [See CDMO profile]
  • ChemCon: API and fine chemical production with expertise in R&D-to-cGMP project transfer. [See CDMO profile]
  • Menadiona: APIs, intermediates and fine chemicals with cGMP processes. [See CDMO profile]
  • Pharmaron: Small molecule manufacturing facilities. [See CDMO profile]
  • Laboratori Alchemia: Custom synthesis of complex or novel molecules. [See CDMO profile]
  • Apeloa: Discovery, development, and manufacturing for APIs, intermediates, and RSMs. [See CDMO profile]
  • Actylis: Process discovery, development, cGMP, and commercial manufacturing. [See CDMO profile]
  • Huiyu Pharmaceuticals: API development and manufacturing. [See CDMO profile]
  • Parimer: Designs, develops, and manufactures new chemical entities. [See CDMO profile]
  • Viswa Laboratories: CRAMS/CDMO, APIs, intermediates and specialty chemicals. [See CDMO profile]
  • 3xper Innoventure Limited: Trusted CRO/CDMO partner. [See CDMO profile]
  • SINOWAY INDUSTRIAL CO., LTD: One-stop CDMO solutions for APIs and key intermediates. [See CDMO profile]
  • Synfine Drugs: Production and export of a broad range of APIs and intermediates. [See CDMO profile]
  • Ascendia Pharmaceutical Solutions: GMP-certified CDMO for advanced sterile and non-sterile pharmaceutical manufacturing, formulation development, and analytical testing. [See CDMO profile]
  • Lukas Heil-Betriebsstätte: High-performance facility complying with the latest GMP standards for sterile and aseptic liquids, especially glass ampoules. [See CDMO profile]
  • Hikal Ltd | Bangalore, India: cGMP process development, scale-up and manufacturing of small molecule APIs, NMEs and intermediates, from gram to kilogram and tonne scale, supporting projects from laboratory stage through commercial launch. [See CDMO profile]
  • Demo facility: Tissue therapy, Cell therapy and GTMP (Gene Therapy). [See CDMO profile]
  • Sichuan Huiyu Pharmaceuticals Co., Ltd: Manufacturing of chemical-synthetic implants, oral solid dosage forms (OSD) and sterile pharmaceutical products. [See CDMO profile]

Related Information

Find Your Ideal Chemical CMO

Looking for the right partner to elevate your chemical manufacturing capabilities? Discover a global network of top-tier chemical CMOs and CDMOs offering expertise in custom synthesis, RSM, intermediates, and API manufacturing. At MAI CDMO Network, we simplify the process of finding your ideal partner, whether for early-stage R&D or large-scale production.

Visit MAI CDMO Network to explore our network or contact us for tailored support in finding the perfect match for your chemical CMO and custom synthesis needs.